Mycobacterium bovis BCG vaccination induces memory CD4+ T cells characterized by effector biomarker expression and anti-mycobacterial activity

Vaccine

Volumn 25, Issue 50, 2007, Pages 8384-8394

  Endsley, Janice J ^a   Hogg, Alison ^b   Shell, Lis J ^a   McAulay, Martin ^b   Coffey, Tracey ^b   Howard, Chris ^b   Capinos Scherer, Charles F ^a   Waters, W Ray ^c   Nonnecke, Brian ^c   Estes, D Mark ^a   Villarreal Ramos, Bernardo ^b  

^a University of Texas Medical Branch School of Medicine   (United States)

^b INSTITUTE FOR ANIMAL HEALTH   (United Kingdom)

^c NATIONAL ANIMAL DISEASE CENTER   (United States)

Author keywords

CD4+ T cells; Cytotoxicity; Tuberculosis

Indexed keywords

BCG VACCINE; GAMMA INTERFERON; GRANULYSIN; INTERLEUKIN 13; INTERLEUKIN 21; INTERLEUKIN 4; PERFORIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBACTERIAL ACTIVITY; ANTIGEN SPECIFICITY; ARTICLE; BCG VACCINATION; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; COW; CYTOKINE PRODUCTION; DRUG MECHANISM; GENETIC TRANSCRIPTION; IMMUNOSTIMULATION; MACROPHAGE; MEMORY T LYMPHOCYTE; MYCOBACTERIUM BOVIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION; TUBERCULOSIS;

ANIMALS; ANTI-INFECTIVE AGENTS; BCG VACCINE; CATTLE; CD4-POSITIVE T-LYMPHOCYTES; CYTOKINES; HUMANS; IMMUNOLOGIC MEMORY; INTERFERON TYPE II; MACROPHAGES; MYCOBACTERIUM BOVIS; PERFORIN; TUBERCULOSIS; TUBERCULOSIS, BOVINE; VACCINATION;

EID: 36249022062     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.10.011     Document Type: Article

References (58)

1. Fauci A.S., Touchette N.A., and Folkers G.K. Emerging infectious diseases: a 10-year perspective from the National Institute of Allergy and Infectious Diseases. Emerg Infect Dis 11 4 (2005) 519-525
2. Nunn P., Williams B., Floyd K., Dye C., Elzinga G., and Raviglione M. Tuberculosis control in the era of HIV. Nat Rev Immunol 5 10 (2005) 819-826
3. Flynn J.L. Immunology of tuberculosis and implications in vaccine development. Tuberculosis (Edinb) 84 1-2 (2004) 93-101
4. Kaufmann S.H. Envisioning future strategies for vaccination against tuberculosis. Nat Rev Immunol 6 9 (2006) 699-704
5. Buddle B.M., Skinner M.A., Wedlock D.N., de Lisle G.W., Vordermeier H.M., and Glyn Hewinson R. Cattle as a model for development of vaccines against human tuberculosis. Tuberculosis (Edinb) 85 1-2 (2005) 19-24
6. Buddle B.M., Wedlock D.N., Parlane N.A., Corner L.A., De Lisle G.W., and Skinner M.A. Revaccination of neonatal calves with Mycobacterium bovis BCG reduces the level of protection against bovine tuberculosis induced by a single vaccination. Infect Immun 71 11 (2003) 6411-6419
7. Hoft D.F., Worku S., Kampmann B., Whalen C.C., Ellner J.J., Hirsch C.S., et al. Investigation of the relationships between immune-mediated inhibition of mycobacterial growth and other potential surrogate markers of protective Mycobacterium tuberculosis immunity. J Infect Dis 186 10 (2002) 1448-1457
8. Kaufmann S.H. How can immunology contribute to the control of tuberculosis?. Nat Rev Immunol 1 1 (2001) 20-30
9. Flynn J.L., and Chan J. Immunology of tuberculosis. Annu Rev Immunol 19 (2001) 93-129
10. Pollock J.M., McNair J., Welsh M.D., Girvin R.M., Kennedy H.E., Mackie D.P., et al. Immune responses in bovine tuberculosis. Tuberculosis (Edinb) 81 1-2 (2001) 103-107
11. Fairbairn I.P., Stober C.B., Kumararatne D.S., and Lammas D.A. ATP-mediated killing of intracellular mycobacteria by macrophages is a P2X(7)-dependent process inducing bacterial death by phagosome-lysosome fusion. J Immunol 167 6 (2001) 3300-3307
12. Smith R.A., Alvarez A.J., and Estes D.M. The P2X7 purinergic receptor on bovine macrophages mediates mycobacterial death. Vet Immunol Immunopathol 78 3-4 (2001) 249-262
13. Tan B.H., Meinken C., Bastian M., Bruns H., Legaspi A., Ochoa M.T., et al. Macrophages acquire neutrophil granules for antimicrobial activity against intracellular pathogens. J Immunol 177 3 (2006) 1864-1871
14. Liu P.T., Stenger S., Tang D.H., and Modlin R.L. Cutting edge: vitamin D-mediated human antimicrobial activity against Mycobacterium tuberculosis is dependent on the induction of cathelicidin. J Immunol 179 4 (2007) 2060-2063
15. Leonard W.J., and Spolski R. Interleukin-21: a modulator of lymphoid proliferation, apoptosis and differentiation. Nat Rev Immunol 5 9 (2005) 688-698
16. Cho S., Mehra V., Thoma-Uszynski S., Stenger S., Serbina N., Mazzaccaro R.J., et al. Antimicrobial activity of MHC class I-restricted CD8+ T cells in human tuberculosis. Proc Natl Acad Sci USA 97 22 (2000) 12210-12215
17. Dieli F., Troye-Blomberg M., Ivanyi J., Fournie J.J., Krensky A.M., Bonneville M., et al. Granulysin-dependent killing of intracellular and extracellular Mycobacterium tuberculosis by Vgamma9/Vdelta2 T lymphocytes. J Infect Dis 184 8 (2001) 1082-1085
18. Stenger S., Hanson D.A., Teitelbaum R., Dewan P., Niazi K.R., Froelich C.J., et al. An antimicrobial activity of cytolytic T cells mediated by granulysin. Science 282 5386 (1998) 121-125
19. Stenger S., Mazzaccaro R.J., Uyemura K., Cho S., Barnes P.F., Rosat J.P., et al. Differential effects of cytolytic T cell subsets on intracellular infection. Science 276 5319 (1997) 1684-1687
20. Canaday D.H., Wilkinson R.J., Li Q., Harding C.V., Silver R.F., and Boom W.H. CD4(+) and CD8(+) T cells kill intracellular Mycobacterium tuberculosis by a perforin and Fas/Fas ligand-independent mechanism. J Immunol 167 5 (2001) 2734-2742
21. Lewinsohn D.M., Bement T.T., Xu J., Lynch D.H., Grabstein K.H., Reed S.G., et al. Human purified protein derivative-specific CD4+ T cells use both CD95-dependent and CD95-independent cytolytic mechanisms. J Immunol 160 5 (1998) 2374-2379
22. Worku S., and Hoft D.F. Differential effects of control and antigen-specific T cells on intracellular mycobacterial growth. Infect Immun 71 4 (2003) 1763-1773
23. Cooper A.M., D'Souza C., Frank A.A., and Orme I.M. The course of Mycobacterium tuberculosis infection in the lungs of mice lacking expression of either perforin- or granzyme-mediated cytolytic mechanisms. Infect Immun 65 4 (1997) 1317-1320
24. Carpenter E., Fray L., and Gormley E. Cellular responses and Mycobacterium bovis BCG growth inhibition by bovine lymphocytes. Immunol Cell Biol 75 6 (1997) 554-560
25. Liebana E., Aranaz A., Aldwell F.E., McNair J., Neill S.D., Smyth A.J., et al. Cellular interactions in bovine tuberculosis: release of active mycobacteria from infected macrophages by antigen-stimulated T cells. Immunology 99 1 (2000) 23-29
26. Skinner M.A., Parlane N., McCarthy A., and Buddle B.M. Cytotoxic T-cell responses to Mycobacterium bovis during experimental infection of cattle with bovine tuberculosis. Immunology 110 2 (2003) 234-241
27. Hein W.R., and Griebel P.J. A road less travelled: large animal models in immunological research. Nat Rev Immunol 3 1 (2003) 79-84
28. Orme I.M. Immunology and vaccinology of tuberculosis: can lessons from the mouse be applied to the cow?. Tuberculosis (Edinb) 81 1-2 (2001) 109-113
29. Buddle B.M. Vaccination of cattle against Mycobacterium bovis. Tuberculosis (Edinb) 81 1-2 (2001) 125-132
30. Pollock J.M., Welsh M.D., and McNair J. Immune responses in bovine tuberculosis: towards new strategies for the diagnosis and control of disease. Vet Immunol Immunopathol 108 1-2 (2005) 37-43
31. + gamma/delta T cells in resistance to Mycobacterium bovis infection in the SCID-bo mouse. J Leukoc Biol 65 1 (1999) 28-34
32. + T cells in bovine tuberculosis in vivo. Infect Immun 71 8 (2003) 4297-4303
33. Waters W.R., Rahner T.E., Palmer M.V., Cheng D., Nonnecke B.J., and Whipple D.L. Expression of L-Selectin (CD62L), CD44, and CD25 on activated bovine T cells. Infect Immun 71 1 (2003) 317-326
34. Vordermeier H.M., Chambers M.A., Cockle P.J., Whelan A.O., Simmons J., and Hewinson R.G. Correlation of ESAT-6-specific gamma interferon production with pathology in cattle following Mycobacterium bovis BCG vaccination against experimental bovine tuberculosis. Infect Immun 70 6 (2002) 3026-3032
35. Endsley J.J., Furrer J.L., Endsley M.A., McIntosh M.A., Maue A.C., Waters W.R., et al. Characterization of Bovine homologues of granulysin and NK-lysin. J Immunol 173 4 (2004) 2607-2614
36. Waters W.R., Palmer M.V., Nonnecke B.J., Thacker T., Scherer C., Estes D.M., Jacobs W., Glatman-Freedman A., and Larsen M. Failure of a Mycobacterium tuberculosis ΔRD1 ΔpanCD double deletion mutant in a neonatal calf aerosol M. bovis challenge model: comparisons to responses elicited by M. bovis bacille Calmette-Guérin. Vaccine 25 45 (2007) 7832-7840
37. Kwong L.S., Hope J.C., Thom M.L., Sopp P., Duggan S., Bembridge G.P., et al. Development of an ELISA for bovine IL-10. Vet Immunol Immunopathol 85 3-4 (2002) 213-223
38. Norimatsu M., Harris J., Chance V., Dougan G., Howard C.J., and Villarreal-Ramos B. Differential response of bovine monocyte-derived macrophages and dendritic cells to infection with Salmonella typhimurium in a low-dose model in vitro. Immunology 108 1 (2003) 55-61
39. Walravens K., Wellemans V., Weynants V., Boelaert F., deBergeyck V., Letesson J.J., et al. Analysis of the antigen-specific IFN-gamma producing T-cell subsets in cattle experimentally infected with Mycobacterium bovis. Vet Immunol Immunopathol 84 1-2 (2002) 29-41
40. Flynn J.L. Lessons from experimental Mycobacterium tuberculosis infections. Microbes Infect 8 4 (2006) 1179-1188
41. Estes D.M., and Brown W.C. Type 1 and type 2 responses in regulation of Ig isotype expression in cattle. Vet Immunol Immunopathol 90 1-2 (2002) 1-10
42. Welsh M.D., Cunningham R.T., Corbett D.M., Girvin R.M., McNair J., Skuce R.A., et al. Influence of pathological progression on the balance between cellular and humoral immune responses in bovine tuberculosis. Immunology 114 1 (2005) 101-111
43. Barry M., and Bleackley R.C. Cytotoxic T lymphocytes: all roads lead to death. Nat Rev Immunol 2 6 (2002) 401-409
44. Toossi Z., Mayanja-Kizza H., Kanost A., Edmonds K., McHugh M., and Hirsch C. Protective responses in tuberculosis: induction of genes for interferon-gamma and cytotoxicity by Mycobacterium tuberculosis and during human tuberculosis. Scand J Immunol 60 3 (2004) 299-306
45. Stenger S. Cytolytic T cells in the immune response to Mycobacterium tuberculosis. Scand J Infect Dis 33 7 (2001) 483-487
46. Dieli F., Sireci G., Caccamo N., Di Sano C., Titone L., Romano A., et al. Selective depression of interferon-gamma and granulysin production with increase of proliferative response by Vgamma9/Vdelta2 T cells in children with tuberculosis. J Infect Dis 186 12 (2002) 1835-1839
47. Thoma-Uszynski S., Stenger S., and Modlin R.L. CTL-mediated killing of intracellular Mycobacterium tuberculosis is independent of target cell nuclear apoptosis. J Immunol 165 10 (2000) 5773-5779
48. Ochoa M.T., Stenger S., Sieling P.A., Thoma-Uszynski S., Sabet S., Cho S., et al. T-cell release of granulysin contributes to host defense in leprosy. Nat Med 7 2 (2001) 174-179
49. Jongstra J., Schall T.J., Dyer B.J., Clayberger C., Jorgensen J., Davis M.M., et al. The isolation and sequence of a novel gene from a human functional T cell line. J Exp Med 165 3 (1987) 601-614
50. Foote M.R., Nonnecke B.J., Fowler M.A., Miller B.L., Beitz D.C., and Waters W.R. Effects of age and nutrition on expression of CD25, CD44, and L-selectin (CD62L) on T-cells from neonatal calves. J Dairy Sci 88 8 (2005) 2718-2729
51. Howard C.J., Sopp P., and Parsons K.R. l-Selectin expression differentiates T cells isolated from different lymphoid tissues in cattle but does not correlate with memory. Immunology 77 2 (1992) 228-234
52. Silva C.L., and Lowrie D.B. Identification and characterization of murine cytotoxic T cells that kill Mycobacterium tuberculosis. Infect Immun 68 6 (2000) 3269-3274
53. Seah G.T., Scott G.M., and Rook G.A. Type 2 cytokine gene activation and its relationship to extent of disease in patients with tuberculosis. J Infect Dis 181 1 (2000) 385-389
54. Brown W.C., Rice-Ficht A.C., and Estes D.M. Bovine type 1 and type 2 responses. Vet Immunol Immunopathol 63 1-2 (1998) 45-55
55. Widdison S., Schreuder L., Villarreal-Ramos B., Howard C., Watson M., and Coffey T. Cytokine expression profiles of bovine lymph nodes: effects of Mycobacterium bovis infection and bacille Calmette-Guérin vaccination. Clin Exp Immunol 144 2 (2006) 281-289
56. Li Y., Bleakley M., and Yee C. IL-21 influences the frequency, phenotype, and affinity of the antigen-specific CD8 T cell response. J Immunol 175 4 (2005) 2261-2269
57. Ma H.L., Whitters M.J., Konz R.F., Senices M., Young D.A., Grusby M.J., et al. IL-21 activates both innate and adaptive immunity to generate potent antitumor responses that require perforin but are independent of IFN-gamma. J Immunol 171 2 (2003) 608-615
58. Suto A., Wurster A.L., Reiner S.L., and Grusby M.J. IL-21 inhibits IFN-gamma production in developing Th1 cells through the repression of Eomesodermin expression. J Immunol 177 6 (2006) 3721-3727